United States · Funded startup

Who invested in Fulcrum Therapeutics

3 rounds we have observed, with the 13 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Raised 11 months ago

Funding summaryUpdated 26 Oct 2026

$310Mraised across 3 rounds since 2016, from 3 sources

$55MSeries A$80MSeries B$175MRound
Latest round
Round, $175MDec 2025
Step-upi
2.2×
Investors
13
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20162018202020222024
$55MSeries A$80MSeries B$175MRound
First round
Series A, $55M
Jul 2016
Biggest round
$175M
Round · Dec 2025
Usual gap between rounds
7.3 years
the median of 2

The rounds

  1. Dec 2025
  2. Sept 2018
    Series B$80M7 new

    Reported by FinSMEsSEC filing: $80M sold, first sale Aug 2018

  3. Jul 2016
    Series A$55M1 new

    Reported by FinSMEsSEC filing: $17M sold, first sale Jul 2016

Founders and team

From Fulcrum Therapeutics's own website and the SEC filings it signed: 12 on the team.

  • Alex C. SapirPresident and Chief Executive Officer, Board Member
  • Alan MussoChief Financial Officer
  • Lisa PercivalChief Regulatory & Quality Assurance Officer
  • Colin HillBoard Member
  • Rachel KingBoard Member
  • Sonja L. BanksBoard Member
  • Bryan StuartExecutive Officeri
  • Diego CadavidExecutive Officeri
  • James GeraghtyBoard Member
  • Kate HavilandChair
  • Owen WallaceExecutive Officeri
  • Robert GouldExecutive Officer, Directori

On the board, as filediAlan EzekowitzJames CollinsKatina DortonMark Levin

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

FidelityVC firm1round
Perceptive AdvisorsAsset manager1round
Foresite CapitalPrivate equity1round
Casdin CapitalVC firm1round
Samsara BioCapitalVC firm1round
SanofiInvestment firm1round
Third Rock VenturesVC firm1round
Section 32VC firm1round
Sanofi VenturesCorporate VC1round
Foresite Capital/ Fidelityno record of our own yet1round
Leerinkno record of our own yet1round
NSno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Fulcrum Therapeutics

Who invested in Fulcrum Therapeutics?

Fulcrum Therapeutics's investors include Fidelity, Perceptive Advisors, Foresite Capital, Casdin Capital and Samsara BioCapital, and 8 more on record.

How much has Fulcrum Therapeutics raised?

Fulcrum Therapeutics has raised $310M across 3 rounds since 2016.

When did Fulcrum Therapeutics last raise?

Fulcrum Therapeutics's most recent round was an Undisclosed round of $175M in Dec 2025.

What was Fulcrum Therapeutics's biggest round?

Its most recent round, $175M in Dec 2025, is also its largest on record.

Who backed Fulcrum Therapeutics first?

Fulcrum Therapeutics's first round on record, in Jul 2016, was backed by Third Rock Ventures.

What stage is Fulcrum Therapeutics at?

Fulcrum Therapeutics's latest named round is an Undisclosed round, in Dec 2025.

Where is Fulcrum Therapeutics based?

Fulcrum Therapeutics is based in the United States.

Companies like Fulcrum Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.